DR. AHANA SEN
DR.AMRITA DEY, DR. KUMAR SAURABH, DR.RUPAK ROY
Abstract
We have reported successful management of subretinal neovascular membrane (SRNVM) in rubella retinopathy with intravitreal ranibizumab for the first time. A 7-year old male and known case of bilateral rubella retinopathy presented to us as part of his annual follow up. Presenting BCVA was 20/80 in right eye and 20/600 in the left eye. On dilated fundoscopy, right eye showed presence of SRNVM and subretinal fluid, along with classical “salt-and-pepper” retinopathy in the right eye. Left eye was poorly dilating and showed a pale disc. The right eye was treated with 2 doses of intravitreal ranibizumab at an interval of 2 months. Post treatment examination showed resolution of SRNVM with scarring, along with significant improvement in BCVA.
Keywords: Rubella retinopathy, anti vegf, ranibizumab, neovascular membrane


Leave a Comment